[登录] [免费注册]
试剂仪器网
位置:首页 > 资料中心 > 化工字典 > 66357-59-3
关键词:       仅模糊查询
CAS: 66357-59-3
分子式: C13H23ClN4O3S
分子量: 350.86
熔点: 133-134 °C
英文名称: 
ah 19065
ranidil
ranigast
zantac
1-ethenediamine,n-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-n'-methyl- 2-nitro- hydrochloride
推荐供应商
货号品牌产品名称规格包装、参考价格详情
R838252MACKLIN盐酸雷尼替丁98%,solid50元/1g;   125元/5g;   375元/25g;   1280元/100g;   3747元/500g;   展开
储存:2-8°C
状态:灰白色到浅黄色粉末
R795611MACKLIN盐酸雷尼替丁10mM in DMSO820元/1ml;   展开
储存:-20°C
R0073TCIRanitidine Hydrochloride>98.0%(T)(HPLC)465元/5G;   1090元/25G;   展开

基本信息

纯度/分析方法>98.0%(T)(HPLC)
分子式/分子量C13H22N4O3S・HCl = 350.86
外观与形状(20℃)固体
储存温度0-10℃
储存在惰性气体下存放于惰性气体之中
应避免的情况空气,加热
相关CAS RN71130-06-8
Reaxys-RN4342707
PubChem物质ID87575630
Merck Index (14)8110
MDL编号MFCD00069339

技术规格

AppearanceWhite to Light yellow powder to crystal
Purity(HPLC)min. 98.0 area%
Purity(Nonaqueous Titration)min. 98.0 %

物性(参考值)

熔点135 ℃(dec.)

安全信息

信号词警告
危险性说明H303 : 吞咽可能有害。
防范说明P312 : 如感觉不适,呼叫急救中心/医生。

相关法规

RTECS#KM6557000
200704J&KRanitidine Hydrochloride98%, 一种组胺H2-受体拮抗剂, IC50为3.3 μM266元/5G;   941元/25G;   展开

基本信息

分子式C13H22N4O3S·HCl
分子量350.86
MDL编码MFCD00069339
Merck14,8110
EINECS 编号266-333-0

产品描述

Ranitidine是组胺H2-受体拮抗剂,IC50为3.3±1.4 μM。

靶点(IC50 & Targe)

H2 receptor

体外研究

Ranitidine使肝细胞从激活的中性粒细胞的毒性产物 被杀死,而Famotidine缺乏这种能力。[1] Ranitidine抑制脂多糖体外刺激的单核细胞产生肿瘤坏死因子-α(TNF-α)。[2] 在分离的豚鼠肝细胞中,Ranitidine剂量依赖性地减少吗啡Kel,最大效应为50%,并增加吗啡-6-葡糖苷酸和吗啡-3-葡糖苷酸的相对浓度。Ranitidine逐渐减小吗啡-3-葡糖苷酸/吗啡-6-葡糖苷酸比高达21%。[3]

体内研究

在大鼠中,Ranitidine导致肝损伤,证据是6小时内增加的血清丙氨酸转氨酶,天冬氨酸转氨酶和γ-谷氨酰转移酶活性。[1] 在大鼠中,Ranitidine导致肝损伤,证据是6小时内增加的血清丙氨酸转氨酶,天冬氨酸转氨酶和γ-谷氨酰转移酶活性。[2] 在LPS/ RAN处理的大鼠中,Ranitidine在肝损伤之前增强LPS诱导的凝固,以及抗凝血剂减少肝损伤。在肝血窦的形成过程中,Ranitidine/LPS处理导致大鼠纤维蛋白凝块,并预防与减少的肝细胞损伤相关的纤维蛋白沉积。在大鼠中,Ranitidine在肝细胞损伤前增强LPS诱导的TNF的增加。[4] 在大鼠中,Ranitidine在高架十字迷宫中表现抗焦虑作用,表现在更多的时间留在开放臂上,更多的最终偏移。[5]

参考文献

[1] Luyendyk JP, et al. J Pharmacol Exp Ther,?003, 307(1), 9-16.

[2] Okajima K, et al. J Pharmacol Exp Ther,?002, 301(3), 1157-1165.

[3] Aasmundstad TA, et al. Pharmacol Toxicol, 1998, 82(6), 272-279.

[4] Tukov FF, et al. Toxicol Sci,?007, 100(1), 267-280.

[5] Privou C, et al. Neuropharmacology,?998, 37(8), 1019-1032.

安全信息

图形或危害标志
提示语Warning
危险说明H302
H410
防范说明P264
P270
P273
P301+P312
P391
P501
UN号码3077
危险分类9
包装等级III
WGK2
RTECSKM6557000
TSCA
B22260Alfa AesarRanitidine Hydrochloride99%630元/5g;   2328元/25g;   展开

应用
An H-2 histamine receptor antagonistRanitidine hydrochloride is mainly used as an H2-receptor antagonist and helps in the treatment of gastrointestinal lesions because of excessive gastric acid secretion. It also serves as an antiulcer drug.

备注
Light sensitive. Incompatible with oxidizing agents.

基本信息

MDL
MFCD00069339

EINECS
266-333-0

分子式
C13H22N4O3S?HCl

分子量
350.86

熔点
ca 134° dec.

灵敏度
Ambient temperatures.

形态
Powder

溶解性
Soluble in water, 2-hydroxypropyl-beta-cyclodextrin, acetic acid, methanol, ethanol and dimethyl sulfoxide. Insoluble in chloroform.

Merck
14,8110

GHS危害和防范说明

Hazard Statements
H303
May be harmful if swallowed.

安全信息

TSCA

R101Sigma-AldrichRanitidine Hydrochloridesolid453.64元/1 G;   1112.6元/5 G;   展开

产品说明

应用

盐酸雷尼替丁已被用作开发和验证平行人工膜渗透性试验 (PAMPA) 的参考化合物。

包装

1, 5 g in poly bottle

生化/生理作用

雷尼替丁主要用于治疗非甾体类抗炎药 (NSAID) 引起的胃肠道损害。
H2 组胺受体拮抗剂;抗溃疡剂。

特点和优势

该化合物由GlaxoSmithKline开发。要浏览其他药物开发化合物和批准的药物/候选药物列表,单击此处。
这种化合物是ADME毒性研究的特色产品。点击此处发现更多特色ADME毒性产品。在sigma.com/discover-bsm可了解更多关于生物活性小分子的其他研究领域。
该化合物出现在受体分类和信号转导手册的组胺受体页。欲浏览其他手册页面,请点击此处。

基本信息

经验(实验)分子式C13H22N4O3S · HCl
分子量350.86
EC 号266-333-0
MDL编号MFCD00069339
PubChem化学物质编号24277803
NACRESNA.77

产品性质

质量水平200
形式solid
颜色 tan
溶解性H2O: 1.8 mg/mL
45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 7.0 mg/mL
创始人GlaxoSmithKline
SMILES stringCl[H].CN\C(NCCSCc1ccc(CN(C)C)o1)=C\[N+]([O-])=O
InChI1S/C13H22N4O3S.ClH/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3;/h4-5,9,14-15H,6-8,10H2,1-3H3;1H/b13-9-;
InChI keyGGWBHVILAJZWKJ-CHHCPSLASA-N
Gene Informationhuman ... HRH2(3274)

安全信息

象形图GHS07GHS08
警示用语:Danger
危险声明H315 - H317 - H319 - H334 - H335
预防措施声明P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
危险分类Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3
靶器官Respiratory system
储存分类代码11 - Combustible Solids
WGKWGK 2
闪点(F)Not applicable
闪点(C)Not applicable
个人防护装备Eyeshields, Gloves, type N95 (US)
R0150000Ranitidine HydrochlorideEuropean Pharmacopoeia (EP) Reference Standard1277.32元/ ;   展开

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

生化/生理作用

H2 组胺受体拮抗剂;抗溃疡剂。

包装

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

注意

Please find SDS provided by EDQM here..

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式C13H22N4O3S · HCl
分子量350.86
MDL编号MFCD00069339
PubChem化学物质编号329823974
NACRESNA.24

产品性质

等级pharmaceutical primary standard
manufacturer/tradenameEDQM
application(s)pharmaceutical (small molecule)
格式neat
储存温度2-8℃
SMILES stringCl[H].CN\C(NCCSCc1ccc(CN(C)C)o1)=C\[N+]([O-])=O
InChI1S/C13H22N4O3S.ClH/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3;/h4-5,9,14-15H,6-8,10H2,1-3H3;1H/b13-9-;
InChI keyGGWBHVILAJZWKJ-CHHCPSLASA-N

安全信息

象形图GHS07GHS08
警示用语:Danger
危险声明H315 - H317 - H319 - H334 - H335
预防措施声明P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
危险分类Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3
靶器官Respiratory system
储存分类代码11 - Combustible Solids
WGKWGK 2
闪点(F)Not applicable
闪点(C)Not applicable
PHR1026SupelcoRanitidine HydrochloridePharmaceutical Secondary Standard; Certified Reference Material1025.53元/500 MG;   展开

产品说明

一般描述

Ranitidine hydrochloride is a H2-receptor antagonist, widely used for the management of hypersecretory conditions and for the treatment of duodenal ulcer.
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.

应用

These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
Ranitidine hydrochloride may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical formulations using titrimetry and visible spectrophotometry techniques.

生化/生理作用

H2 histamine receptor antagonist; anti-ulcer agent.
H2 组胺受体拮抗剂;抗溃疡剂。

分析说明

These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available.

其他说明

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

附注

To see an example of a Certificate of Analysis for this material enter LRAA5630 in the slot below. This is an example certificate only and may not be the lot that you receive.

基本信息

经验(实验)分子式C13H22N4O3S · HCl
分子量350.86
EC 号266-333-0
MDL编号MFCD00069339
PubChem化学物质编号329823056
NACRESNA.24

产品性质

质量水平300
等级certified reference material
pharmaceutical secondary standard
CofAcurrent certificate can be downloaded
technique(s)HPLC: suitable
gas chromatography (GC): suitable
application(s)pharmaceutical (small molecule)
格式neat
药典可追溯性traceable to BP 471
traceable to PhEur R0150000
traceable to USP 1598405
储存温度2-30℃
SMILES stringCl[H].CN\C(NCCSCc1ccc(CN(C)C)o1)=C\[N+]([O-])=O
InChI1S/C13H22N4O3S.ClH/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3;/h4-5,9,14-15H,6-8,10H2,1-3H3;1H/b13-9-;
InChI keyGGWBHVILAJZWKJ-CHHCPSLASA-N

安全信息

象形图GHS07GHS08
警示用语:Danger
危险声明H315 - H317 - H319 - H334 - H335
预防措施声明P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
危险分类Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3
靶器官Respiratory system
储存分类代码11 - Combustible Solids
WGKWGK 2
闪点(F)Not applicable
闪点(C)Not applicable
Y0001787Ranitidine for impurity A identificationEuropean Pharmacopoeia (EP) Reference Standard1277.32元/ ;   展开

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

生化/生理作用

H2 组胺受体拮抗剂;抗溃疡剂。

包装

Unit quantity: 15mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式C13H22N4O3S · HCl
分子量350.86
MDL编号MFCD00069339
PubChem化学物质编号329831573
NACRESNA.24

产品性质

等级pharmaceutical primary standard
manufacturer/tradenameEDQM
application(s)pharmaceutical (small molecule)
格式neat
储存温度2-8℃
SMILES stringCl[H].CN\C(NCCSCc1ccc(CN(C)C)o1)=C\[N+]([O-])=O
InChI1S/C13H22N4O3S.ClH/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3;/h4-5,9,14-15H,6-8,10H2,1-3H3;1H/b13-9-;
InChI keyGGWBHVILAJZWKJ-CHHCPSLASA-N

安全信息

象形图GHS07GHS08
警示用语:Danger
危险声明H315 - H317 - H319 - H334 - H335
预防措施声明P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
危险分类Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3
靶器官Respiratory system
储存分类代码11 - Combustible Solids
WGKWGK 2
闪点(F)Not applicable
闪点(C)Not applicable
1598405USPRanitidine HydrochlorideUnited States Pharmacopeia (USP) Reference Standard3231.47元/200 MG;   展开

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

生化/生理作用

H2 组胺受体拮抗剂;抗溃疡剂。

分析说明

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他说明

USP issued SDS can be found here.
Sales restrictions may apply.

基本信息

经验(实验)分子式C13H22N4O3S · HCl
分子量350.86
MDL编号MFCD00069339
PubChem化学物质编号329751022
NACRESNA.24

产品性质

等级pharmaceutical primary standard
secondary reference material (pharmaceutical)
manufacturer/tradenameUSP
application(s)pharmaceutical (small molecule)
格式neat
SMILES stringCl[H].CN\C(NCCSCc1ccc(CN(C)C)o1)=C\[N+]([O-])=O
InChI1S/C13H22N4O3S.ClH/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3;/h4-5,9,14-15H,6-8,10H2,1-3H3;1H/b13-9-;
InChI keyGGWBHVILAJZWKJ-CHHCPSLASA-N

安全信息

象形图GHS07GHS08
警示用语:Danger
危险声明H315 - H317 - H319 - H334 - H335
预防措施声明P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
危险分类Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3
靶器官Respiratory system
储存分类代码11 - Combustible Solids
WGKWGK 2
闪点(F)Not applicable
闪点(C)Not applicable
BP471Ranitidine HydrochlorideBritish Pharmacopoeia (BP) Reference Standard1952.55元/100 MG;   展开

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

生化/生理作用

H2 组胺受体拮抗剂;抗溃疡剂。

包装

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式C13H22N4O3S · HCl
分子量350.86
EC 号266-333-0
MDL编号MFCD00069339
NACRESNA.24

产品性质

等级pharmaceutical primary standard
manufacturer/tradenameBP
格式neat
储存温度2-8℃
SMILES stringCl[H].CN\C(NCCSCc1ccc(CN(C)C)o1)=C\[N+]([O-])=O
InChI1S/C13H22N4O3S.ClH/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3;/h4-5,9,14-15H,6-8,10H2,1-3H3;1H/b13-9-;
InChI keyGGWBHVILAJZWKJ-CHHCPSLASA-N

安全信息

储存分类代码11 - Combustible Solids
WGKWGK 2
闪点(F)Not applicable
闪点(C)Not applicable
243895FluorochemNoctone95%220元/500mg;   924元/5g;   2178元/25g;   展开

基本信息

CAS Number66357-59-3
MDL NumberMFCD00069339
CAS号首数字顺序排列: 1 2 3 4 5 6 7 8 9